Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The

López López, Rafael

Estatísticas

Estatísticas

Ver Estatísticas de uso

Identificadores

Identificadores

URI: http://hdl.handle.net/20.500.11940/3737

ISSN: 095-9804

Rexistro completo

Servizos

Servizos

RIS

Mendeley

Linksolver

Data de publicación

2015

Tipo de contido

Publicación de congreso